- Home
- YUMC vs ROIV Comparison
YUMC vs ROIV Comparison
Compare YUMC & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YUMC
- ROIV
- Stock Information
- Founded
- YUMC 1987
- ROIV 2014
- Country
- YUMC China
- ROIV United Kingdom
- Employees
- YUMC N/A
- ROIV N/A
- Industry
- YUMC Restaurants
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- YUMC Consumer Discretionary
- ROIV Health Care
- Exchange
- YUMC Nasdaq
- ROIV Nasdaq
- Market Cap
- YUMC 15.6B
- ROIV 14.0B
- IPO Year
- YUMC N/A
- ROIV N/A
- Fundamental
- Price
- YUMC $48.32
- ROIV $20.23
- Analyst Decision
- YUMC
- ROIV Strong Buy
- Analyst Count
- YUMC 0
- ROIV 8
- Target Price
- YUMC N/A
- ROIV $21.19
- AVG Volume (30 Days)
- YUMC 1.4M
- ROIV 8.7M
- Earning Date
- YUMC 11-04-2025
- ROIV 11-10-2025
- Dividend Yield
- YUMC 2.00%
- ROIV N/A
- EPS Growth
- YUMC 6.57
- ROIV N/A
- EPS
- YUMC 2.40
- ROIV N/A
- Revenue
- YUMC $11,569,000,000.00
- ROIV $20,329,000.00
- Revenue This Year
- YUMC $5.94
- ROIV N/A
- Revenue Next Year
- YUMC $5.73
- ROIV $320.50
- P/E Ratio
- YUMC $20.05
- ROIV N/A
- Revenue Growth
- YUMC 3.29
- ROIV N/A
- 52 Week Low
- YUMC $41.00
- ROIV $8.73
- 52 Week High
- YUMC $53.99
- ROIV $21.35
- Technical
- Relative Strength Index (RSI)
- YUMC 70.14
- ROIV 61.82
- Support Level
- YUMC $45.83
- ROIV $20.07
- Resistance Level
- YUMC $48.63
- ROIV $20.99
- Average True Range (ATR)
- YUMC 1.03
- ROIV 0.77
- MACD
- YUMC 0.33
- ROIV -0.21
- Stochastic Oscillator
- YUMC 94.64
- ROIV 44.31
About YUMC Yum China Holdings Inc.
With more than 16,000 units and almost USD 12 billion in systemwide sales in 2024, Yum China is the largest restaurant operator in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (11,648 units) and Pizza Hut (3,724), but the company's portfolio also includes other brands such as Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza (collectively representing more than 1,000 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.